1. Home
  2. ARQT vs TNK Comparison

ARQT vs TNK Comparison

Compare ARQT & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • TNK
  • Stock Information
  • Founded
  • ARQT 2016
  • TNK 2007
  • Country
  • ARQT United States
  • TNK Bermuda
  • Employees
  • ARQT N/A
  • TNK N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • TNK Marine Transportation
  • Sector
  • ARQT Health Care
  • TNK Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • TNK Nasdaq
  • Market Cap
  • ARQT 1.7B
  • TNK 1.6B
  • IPO Year
  • ARQT 2020
  • TNK 2007
  • Fundamental
  • Price
  • ARQT $15.76
  • TNK $44.04
  • Analyst Decision
  • ARQT Strong Buy
  • TNK Buy
  • Analyst Count
  • ARQT 6
  • TNK 3
  • Target Price
  • ARQT $18.80
  • TNK $50.67
  • AVG Volume (30 Days)
  • ARQT 2.0M
  • TNK 577.7K
  • Earning Date
  • ARQT 08-13-2025
  • TNK 07-31-2025
  • Dividend Yield
  • ARQT N/A
  • TNK 4.54%
  • EPS Growth
  • ARQT N/A
  • TNK N/A
  • EPS
  • ARQT N/A
  • TNK 9.52
  • Revenue
  • ARQT $212,819,000.00
  • TNK $1,092,689,000.00
  • Revenue This Year
  • ARQT $61.01
  • TNK N/A
  • Revenue Next Year
  • ARQT $37.95
  • TNK N/A
  • P/E Ratio
  • ARQT N/A
  • TNK $4.63
  • Revenue Growth
  • ARQT 100.03
  • TNK N/A
  • 52 Week Low
  • ARQT $7.86
  • TNK $33.35
  • 52 Week High
  • ARQT $17.75
  • TNK $66.25
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 60.23
  • TNK 48.72
  • Support Level
  • ARQT $13.06
  • TNK $42.42
  • Resistance Level
  • ARQT $15.36
  • TNK $44.79
  • Average True Range (ATR)
  • ARQT 0.66
  • TNK 1.48
  • MACD
  • ARQT 0.12
  • TNK -0.01
  • Stochastic Oscillator
  • ARQT 82.57
  • TNK 47.59

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the global oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

Share on Social Networks: